Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Goodman Continues On Rising Star Arc As FDA’s Chief Medical Officer

This article was originally published in The Tan Sheet

Executive Summary

Jesse Goodman has become FDA's acting chief medical officer and is the agency's lone representtative on the Federal Coordinating Committee on Comparative Effectiveness Research

You may also be interested in...

Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA

FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say

Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein

The White House is set to nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner, according to sources knowledgeable about the selection process

Plan For Spending Comparative Effectiveness Money Due July 30

Questions swirling around the $1.1 billion in comparative effectiveness research funding should be answered by July 30, the due date for a report to Congress with details of how the money provided in the economic stimulus package for the research will be spent





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts